University College Dublin.
Trinity College Dublin, The University of Dublin.
Behav Ther. 2020 Jan;51(1):162-177. doi: 10.1016/j.beth.2019.06.003. Epub 2019 Jun 12.
There is a major public health need for innovative and efficacious behavioral and cognitive interventions for smoking cessation. This randomized controlled trial evaluated the efficacy of an acceptance and commitment therapy (ACT) smartphone application in augmenting ACT group treatment for smoking cessation. One hundred fifty adults smoking 10 or more cigarettes per day were randomly assigned to 6 weekly group sessions of behavioral support, ACT, or ACT combined with the smartphone application. Access to the app was provided from the start of the in-person treatment until the 6-month follow-up assessment. Participants were encouraged to make their quit attempts after the third session, and the posttreatment assessment occurred 3 weeks later. Measures of smoking status and ACT processes were obtained at baseline, posttreatment, and 6-month follow-up. Biochemically verified quit rates in the combined, ACT, and behavioral support groups were 36% (p = .079 relative to ACT; p = .193 relative to behavioral support), 20% (p = .630 relative to behavioral support) and 24% at posttreatment, as compared with 24% (p = .630 relative to behavioral support), 24% (p = .630 relative to behavioral support) and 20% at follow-up. There was no significant difference (p = > .999) in the primary outcome of biochemically verified 7-day point-prevalence abstinence at 6-month follow-up between the combined and ACT groups. The combined group reported significantly greater smoking reduction, acceptance and present-moment awareness than the behavioral support group at posttreatment, but not at follow-up. There were no significant differences between the groups in positive mental health. Contrary to hypotheses, the ACT group did not display significant improvements in positive mental health or ACT processes relative to the behavioral support group at posttreatment or follow-up. Implications and directions for future research are discussed.
目前,人们非常需要创新且有效的行为和认知戒烟干预措施。本随机对照试验评估了接受和承诺疗法(ACT)智能手机应用程序在增强 ACT 团体戒烟治疗中的疗效。150 名每天吸烟 10 支或以上的成年人被随机分配到 6 周的行为支持、ACT 或 ACT 联合智能手机应用程序组。从面对面治疗开始到 6 个月的随访评估,都可以使用该应用程序。参与者被鼓励在第三次会议后尝试戒烟,治疗后评估在 3 周后进行。在基线、治疗后和 6 个月随访时测量吸烟状况和 ACT 过程。在联合、ACT 和行为支持组中,生物验证的戒烟率在治疗后分别为 36%(与 ACT 相比,p=0.079;与行为支持相比,p=0.193)、20%(与行为支持相比,p=0.630)和 24%,而在随访时分别为 24%(与行为支持相比,p=0.630)、24%(与行为支持相比,p=0.630)和 20%。在 6 个月随访时,生物验证的 7 天点患病率戒断的主要结局在联合组和 ACT 组之间没有显著差异(p>0.999)。与行为支持组相比,联合组在治疗后报告的吸烟量减少、接受度和当下意识显著增加,但在随访时没有增加。两组在积极心理健康方面没有显著差异。与假设相反,与行为支持组相比,ACT 组在治疗后或随访时,其积极心理健康或 ACT 过程均未显示出显著改善。讨论了对未来研究的影响和方向。